C. Kelly

Pathologic complete response (pCR) to neoadjuvant treatment with or without atezolizumab in triple negative, early high-risk and locally advanced breast cancer. NeoTRIP Michelangelo randomized study.

P. Valagussa, S. Russo, R. Greil, 2022, Annals of oncology : official journal of the European Society for Medical Oncology.

Geriatric assessment-driven intervention (GAIN) on chemotherapy toxicity in older adults with cancer: A randomized controlled trial.

M. Fakih, R. Jayani, W. Dale, 2020 .

Geriatric Assessment-Driven Intervention (GAIN) on Chemotherapy-Related Toxic Effects in Older Adults With Cancer: A Randomized Clinical Trial.

M. Fakih, R. Jayani, W. Dale, 2021, JAMA oncology.